Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Atomically dispersed copper(I) on tungstosilicic acid for catalytic protection against cisplatin-induced hearing loss
Xiaochan Lua,
Yin Chenbc,
Yanmei Moa,
Qingdong Zenga,
Shaoqin Cenbc,
Li Zenga,
Hongyi Hua,
Ao Li*bc,
Xia Gao*bc and
Bin Zhang*a
aDepartment of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen Institute of Translational Medicine, Shenzhen Second People’s Hospital, Shenzhen, 518036, China. E-mail: binzhang@email.szu.edu.cn
bDepartment of Otolaryngology Head and Neck Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Jiangsu Provincial Key Medical Discipline (Laboratory), Nanjing, 210008, China. E-mail: 116961718@qq.com; xiagaogao@hotmail.com
cDepartment of Otolaryngology and Head-and-Neck Surgery, Nanjing Drum Tower Hospital, Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, 210008, China
First published on 20th May 2026
Abstract
Correction for ‘Atomically dispersed copper(I) on tungstosilicic acid for catalytic protection against cisplatin-induced hearing loss’ by Xiaochan Lu et al., J. Mater. Chem. B, 2025, 13, 3540–3552, https://doi.org/10.1039/D4TB02820A.
The authors regret that in the original article, two of the images in Fig. 4D displayed overlapping areas of the same sample owing to an accidental error during Figure preparation – these were the BASE images for the ‘Cu SAN’ and ‘Cu SAN + CIS’ samples. A corrected version of Fig. 4D is shown below, followed by a corrected version of the complete Fig. 4. The authors confirm that all conclusions were arrived at based on the correct images and that this change does not affect the Results and Discussion of the original article. Shenzhen Second People’s Hospital and Nanjing Drum Tower Hospital have confirmed the integrity and reliability of the corrected data.
 | ||
| Fig. 4 Evaluation of the capabilities of Cu SAN against cisplatin-associated ototoxicity in vivo. (A) The timeline for the animal testing. (B) The hearing threshold prior to the various treatments (n = 4). (C) The hearing threshold after different treatments (n = 4). (D) Characterization of apical, middle, and basal turns of the cochlea for each experimental group were shown by immunofluorescence. Hair cells were stained with Myosin7a (red). (E) Statistical evaluation of hair cell survival in each group (n = 4). (F) SOD concentrations in the cochlea after various treatments. The results are presented as mean ± SD; n = 4; **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s. = not significant. Scale bars: 20 µm. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2026 |